Goldman Sachs Asset Management (GSAM) has launched a new portfolio that will provide exposure to global companies at the "forefront" of healthcare innovation, with a focus on genomics, precision medicine, minimally invasive procedures and digitisation.
The Goldman Sachs Global Future Health Care Equity Portfolio, a new sub-fund of the UCITS-qualifying Luxembourg-domiciled Goldman Sachs Funds SICAV, will be managed by GSAM's 80-person fundamental equity team with the intention to generate superior long-term returns for investors. Luke Barrs, head of GSAM fundamental equity client portfolio management in EMEA, said: "Innovation in healthcare had already brought the global industry to an inflection point, but the pandemic has supercharged an existing secular trend, and pushed healthcare right to the top of governments' and societies' prio...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
